U.S. Bancorp

Recent news

• U.K. Current Account For Q2 -19.9B Vs. -25.6B Est.; -21.1B (Revised) Prior
  Benzinga · 2026/9/30
• Fed's Says No Administrative Misconduct Found In Review Of Fed Building Project In Washington, Though Management Deficiencies Were Identified; ~$1B Cost Overrun In Building Renovation Was Key In Dispute Between Then-Fed Chief Powell, Trump And U.S....
  Benzinga · 2026/10/1
• Rating change
  B of A Securities Upgrades U.S. Bancorp to Buy, Raises Price Target to $40
  Benzinga · 2023/7/11
• HPE Receives $1.2B Order From Closely Held Cloud Infrastructure Provider Vultr To Deploy AMD Helios AI Racks At Its U.S. Cloud Data Centers
  Benzinga · 2026/9/30
• Company notice
  ALEBUND-B: VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG APPLICATION FOR AP308 FOR THETREATMENT OF IgA NEPHROPATHY CLEARED BY THE U.S. FOOD ANDDRUG ADMINISTRATION
  HKEX · 2026/9/8
• Rating change
  HuaLing Pharma-B (2552.HK): Huatangning Fuels Rapid Revenue Growth; Second-Generation GKA Clinical Trials in the U.S. Accelerate
  Guoyuan International · 2026/3/27
• Rating change
  [Broker Focus] Guoyuan International gives a Buy rating to Hua Medicine-B (02552), citing the rapid sales growth of Huatangning and the expedited U.S. clinical trials for its second-generation GKA.
  Jinwu Information · 2025/9/19
• Rating change
  B of A Securities Maintains Buy on U.S. Bancorp, Raises Price Target to $45
  Benzinga · 2023/7/20
• Rating change
  Hua Medicine-B (2552.HK): Huatingning continues to ramp up sales; U.S. clinical data for the second-generation GKA expected to be released within the year.
  Guoyuan International · 2026/9/17
• Rating change
  B of A Securities Maintains Buy on U.S. Bancorp, Raises Price Target to $55
  Benzinga · 2025/10/17
• B. Riley states that the re-release of "Avengers: Endgame" drove U.S. third-quarter box office receipts to a record high.
  AASTOCKS · 2026/9/29
• Company notice
  GungHo Online Entertainment: The co-op bullet-hell shooter for Steam, "B.L.U.E. NOVA," is scheduled for release in 2027!
  JPX · 2026/9/14
• HK Stock Market Update | Libang Pharmaceutical-B (09637) surges nearly 8% in afternoon trading after AP308/PKU308 receives U.S. FDA clearance for clinical trials
  Zhitong Finance · 2026/9/29
• Rating change
  Keji Pharmaceutical-B (02171.HK): CAR-T U.S. production capacity ready solid tumors are worth looking forward to
  國金證券 · 2023/8/24
• Rating change
  Research Alert: Wsp Creates #1 U.s. Power & Energy Platform Through Cad4.5b Trc Buyout
  MT Newswires · 2025/12/16
• Company notice
  ASCLETIS-B: VOLUNTARY ANNOUNCEMENT -ASCLETIS ANNOUNCES POSITIVE RESULTS FROM 28-DAYPROOF-OF-CONCEPT CLINICAL STUDY IN U.S. FOR ASC50,A FIRST-IN-CLASS AND BEST-IN-CLASS ORAL SMALLMOLECULE IL-17A INHIBITOR FOR THE TREATMENTOF PLAQUE PSORIASIS
  HKEX · 2026/9/29
• Company notice
  GungHo Online Entertainment: Co-op PvE Shooter for Steam 『 B.L.U.E. NOVA』 Scheduled for release in 2027!
  JPX · 2026/9/14
• Company notice
  ASCLETIS-B: VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES INITIATION OF PHASE I STUDY IN U.S.FOR ORAL AMYLIN RECEPTOR PEPTIDE AGONIST ASC36 FOR THETREATMENT OF OBESITY
  HKEX · 2026/9/8
• XTEND AI Robotics Selected As Top Performer In U.S. Department Of War's $1B Drone Dominance Program Gauntlet II Following Delivery And Demonstration Of 120 STRIKER Systems
  Benzinga · 9/17
• Looming Biosimilar Void Risks $189B in Lost U.S. Healthcare Savings: Report
  Seeking Alpha · 9/18
• U.S. State Dept Approves Potential Sale Of F-35 Lightning II Joint Strike Fighter Aircraft To Saudi Arabia For An Estimated $24.3B
  Benzinga · 9/18
• Northrop Grumman CEO Speaking At The Morgan Stanley Laguna Conference Says U.S. Air Force To Conclude B-21 Fleet-Size Review By Year-End; "We Are Far Along In Discussions With Lockheed Martin As To Be The Solid Rocket Motor Provider For A Portion Of...
  Benzinga · 9/18
• GoldHaven Ties U.S. Tungsten Push to Drilling Progress at B.C.'s Magno Project
  TipRanks · 9/17
• U.K. Trade Balance For July -20.97B Vs. -22.60B Est.; -23.01B Prior
  Benzinga · 9/11
• Company notice
  BAO PHARMA-B: VOLUNTARY ANNOUNCEMENT - IND FOR SUBCUTANEOUS INFUSION OF KJ015 FOR INJECTION (SC) WAS APPROVED BY U.S. FDA
  HKEX · 8/24

Headlines are aggregated automatically and are not independently verified or edited by our team.